● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

MOREPENLAB

BSE
Morepen Laboratories Limited
Healthcare· Pharmaceuticals & Biotechnology· INE083A01026· Scrip: 500288
ENहिन्दीગુજરાતીमराठी
49.37
0.73 (+0.00%)
2026-06-10
BSE
49.37
0.73
+0.00%
344250586606-1608-0710-0311-2801-2303-2005-2506-10
233 trading days · 1Y period
TODAY (BSE)
Open48.95
High51.80
Low47.80
Prev Close48.64
Volume21.81L
Value₹10.9Cr
L: 47.80H: 51.80
Info
Face Value₹2
Listed1999-11-24
ISININE083A01026
SeriesA
BSE Scrip500288

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue+3.44%
PAT-23.42%
EPS-24.62%
Profitability
Dividend
TTM Revenue
₹1699 Cr
TTM EBITDA
₹227 Cr
TTM PAT
₹125 Cr
TTM EPS
₹2.37
Rev/Share
₹31.0

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr113 Cr226 Cr340 Cr453 Cr22-1223-0323-0923-1224-0324-0624-0924-120.10.20.40.60.50.70.70.5
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31453 Cr423 Cr50 Cr35 Cr27 Cr0.49
2024-09-30438 Cr397 Cr60 Cr46 Cr35 Cr0.65
2024-06-30386 Cr342 Cr51 Cr47 Cr35 Cr0.69
2024-03-31423 Cr385 Cr66 Cr42 Cr28 Cr0.54
2023-12-31445 Cr405 Cr67 Cr44 Cr32 Cr0.63
2023-09-30422 Cr396 Cr44 Cr29 Cr21 Cr0.42
2023-03-31364 Cr356 Cr22 Cr11 Cr8 Cr0.16
2022-12-31348 Cr336 Cr27 Cr14 Cr9 Cr0.15

Shareholding Pattern

CURRENT2026-03-31
35.6%PROMOTER
Promoter35.6%
FII1.6%
DII1.3%
Public64.3%
Govt0.0%
PROMOTER HOLDING TREND
35.6%24-0835.6%24-0935.6%24-1235.6%25-0335.6%25-0935.6%25-1235.6%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-29DividendDividend - Re 0.20 Per Share
2024-09-20OtherAnnual General Meeting
2023-09-21OtherAnnual General Meeting
2022-09-19OtherAnnual General Meeting
2021-09-20Other Annual General Meeting
2020-09-22Other Annual General Meeting
2019-09-05Other Annual General Meeting
2018-09-12Other Annual General Meeting
2017-09-14Other Annual General Meeting
2016-09-15Other Annual General Meeting
2015-09-10Other Annual General Meeting
2014-09-11OtherAnnual General Meeting
2014-08-08OtherE - Voting
2013-09-05OtherAnnual General Meeting
2012-09-07OtherAnnual General Meeting
2011-09-09OtherAnnual General Meeting
2009-09-11OtherAnnual General Meeting
2008-06-27OtherAnnual General Meeting
2007-08-17OtherAgm
2006-09-18OtherAgm

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-1048.9051.8047.7149.374.97Cr
2026-06-0346.0046.1044.1145.4035.85L
2026-05-2742.8042.8041.3842.2274.86L
2026-05-2644.0045.4543.6143.9245.54L
2026-05-2543.4544.0443.0043.7222.82L
2026-05-2243.1944.7942.5142.9139.92L
2026-05-2143.4443.7642.8242.9822.36L
2026-05-2041.4942.9041.1042.5226.75L
2026-05-1941.5042.6341.5041.8620.18L
2026-05-1841.0041.6339.6941.3027.02L
2026-05-1542.7042.9941.8241.9420.13L
2026-05-1444.4544.5542.7043.0129.17L
2026-05-1342.7044.7542.7043.9032.36L
2026-05-1245.7945.9042.7642.9444.90L
2026-05-1145.8247.0044.8045.7979.42L
2026-05-0844.1546.5644.1045.6492.61L
2026-05-0743.9544.2943.3044.0335.50L
2026-05-0642.2043.9042.2043.5445.27L
2026-05-0541.8142.7241.6741.9918.07L
2026-05-0441.8042.6641.6042.0020.47L
2026-04-3041.5141.7540.9041.3616.05L
2026-04-2942.3942.6441.6241.7720.87L
2026-04-2843.6043.8542.0042.2034.67L
2026-04-2742.1043.6042.1043.2730.55L
2026-04-2442.8143.3541.5241.7226.67L
2026-04-2342.9744.1842.5142.6951.25L
2026-04-2241.8043.3541.5643.0746.98L
2026-04-2141.0042.4041.0041.8021.65L
2026-04-2042.2542.4440.6541.2930.52L
2026-04-1741.0043.1841.0041.9063.99L

Frequently Asked Questions

About

Morepen Laboratories Limited is an Indian pharmaceutical company that develops, manufactures, and markets a range of products including active pharmaceutical ingredients (APIs), generic and branded formulations, and home health products. The company has a strong presence in the Indian market and is recognized for its commitment to quality and innovation in the healthcare sector. Founded in 1992, Morepen Laboratories has established itself as a key player in the pharmaceutical industry.

BOARD OF DIRECTORS